Clinical trial
SAPIEN 3 Ultra System Post-Market Clinical Follow-up Study
NCT04555967 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAPIEN 3 Ultra System Post-Market Clinical Follow-up Study
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 30, 2020
- Completion date
- November 30, 2026
- Enrollment
- 200 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.